Rolitetracycline
Appearance
This article needs additional citations for verification. (December 2014) |
Clinical data | |
---|---|
Other names | (2Z,4S,4aS,5aS,6S,12aS)-4-Dimethylamino-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.010.938 |
Chemical and physical data | |
Formula | C27H33N3O8 |
Molar mass | 527.574 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Rolitetracycline is a tetracycline antibiotic.[1] Tetracycline is N-Mannich base prodrug that is prepared from tetracycline by condensation with pyrrolidine and formaldehyde to produce rolitetracycline. Rolitetracycline is used as an antibacterial drug, a protein synthesis inhibitor, an antiprotozoal drug and a prodrug.[2][3]
References
[edit]- ^ "Rolitetracycline". PubChem. National Library of Medicine. Retrieved 8 June 2020.
- ^ PubChem. "Rolitetracycline". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-07-29.
- ^ Smith L (January 1964). "Rolitetracycline, an antibiotic for parenteral use. (syntetrin, velacycline)". JAMA. 187 (2): 141. doi:10.1001/jama.1964.03060150065017. PMID 14066734.